Breadcrumb

CTB News

The unexpected role of chloride channels in a rare neurological disorder

A new study finds mutations affecting the chloride channel of a glutamate transport protein in a rare disorder...

Where immune cells are located is critical for cancer immune therapy, a new study shows

An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a...

TB and COVID-19, a joint battle?

On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.

RI-MUHC team receives Discovery of the Year Award from Québec Science magazine

Jean-Jacques Lebrun’s team at the RI-MUHC has won the 2021 Québec Science Discovery of the Year Award...

Cecilia Costiniuk receives 2022 CAHR-CANFAR Excellence in Research Award

RI-MUHC researcher is committed to improving the lives of those living with HIV

RI-MUHC trainee honoured by the American Association for Cancer Research

Yasmine Benslimane is investigating how the female hormone estrogen influences the spread of colon cancer...

LSD, a future antianxiety pill?

A new study by Dr. Gabriella Gobbi reveals the neurobiological mechanisms by which LSD could relieve anxiety

BCG vaccine provides protection against influenza virus but not SARS-CoV-2

A new study led by RI-MUHC researchers reveals that the 100-year-old tuberculosis vaccine known as..

What’s the signature of a healthy heart?

Instead of treating the “average person,” the Courtois Cardiovascular Signature Program aims to treat every person as a unique individual

COVID-19: A close look at vaccine strategies used with older people in Quebec

A new study determines the maximum recommended interval between the first and second doses of mRNA...

Explore news and events at the RI-MUHC